Various neurotransmitter receptors

The term 'Various neurotransmitter receptors' refers to a broad and heterogeneous collection of membrane-bound proteins that mediate chemical signaling within the central and peripheral nervous systems. These receptors are fundamentally divided into two classes: ionotropic receptors, which are ligand-gated ion channels providing rapid synaptic transmission, and metabotropic receptors, which are G protein-coupled receptors (GPCRs) that initiate slower, prolonged intracellular signaling cascades (NIH, 2022). They respond to a diverse array of endogenous ligands, including amino acids (glutamate, GABA), biogenic amines (dopamine, serotonin, norepinephrine), and acetylcholine, to regulate essential physiological processes such as mood, cognition, motor control, and autonomic function (StatPearls, 2023). Dysregulation of these receptor systems is a hallmark of numerous complex conditions, including schizophrenia, depression, Alzheimer's disease, and Parkinson's disease (PubMed, 2021). Many pharmacological agents, particularly 'atypical' antipsychotics and tricyclic antidepressants, are characterized by their 'dirty' binding profiles, meaning they interact with multiple distinct receptor types simultaneously to achieve therapeutic effects. While this multi-target approach can be effective for complex syndromes, it often results in a wide range of off-target side effects due to the ubiquitous expression of these receptors throughout the body (Wikipedia, 2024). This entry is marked as incorrect because it represents a functional category rather than a single, specific therapeutic target.

Other names

Neurotransmitter receptorsSynaptic receptorsLigand-gated ion channels and GPCRs

Drugs targeting various neurotransmitter receptors typically act as agonists, antagonists, or allosteric modulators across multiple receptor families (e.g., dopaminergic, serotonergic, adrenergic, and cholinergic) to restore neurochemical balance (StatPearls, 2023).